Department of Psychiatry and Behavioral Neurosciences, University of Chicago, USA.
Department of Psychology, University of Chicago, USA.
Pharmacol Biochem Behav. 2014 Feb;117:1-6. doi: 10.1016/j.pbb.2013.11.030. Epub 2013 Dec 3.
3-4-Methylenedioxymethamphetamine (MDMA) increases self-reported positive social feelings and decreases the ability to detect social threat in faces, but its effects on experiences of social acceptance and rejection have not been determined. We examined how an acute dose of MDMA affects subjective and autonomic responses to simulated social acceptance and rejection. We predicted that MDMA would decrease subjective responses to rejection. On an exploratory basis, we also examined the effect of MDMA on respiratory sinus arrhythmia (RSA), a measure of parasympathetic cardiac control often thought to index social engagement and emotional regulation. Over three sessions, healthy adult volunteers with previous MDMA experience (N=36) received capsules containing placebo, 0.75 or 1.5 mg/kg of MDMA under counter-balanced double-blind conditions. During expected peak drug effect, participants played two rounds of a virtual social simulation task called "Cyberball" during which they experienced acceptance in one round and rejection in the other. During the task we also obtained electrocardiograms (ECGs), from which we calculated RSA. After each round, participants answered questionnaires about their mood and self-esteem. As predicted, MDMA decreased the effect of simulated social rejection on self-reported mood and self-esteem and decreased perceived intensity of rejection, measured as the percent of ball tosses participants reported receiving. Consistent with its sympathomimetic properties, MDMA decreased RSA as compared to placebo. Our finding that MDMA decreases perceptions of rejection in simulated social situations extends previous results indicating that MDMA reduces perception of social threat in faces. Together these findings suggest a cognitive mechanism by which MDMA might produce pro-social behavior and feelings and how the drug might function as an adjunct to psychotherapy. These phenomena merit further study in non-simulated social environments.
3,4-亚甲二氧基甲基苯丙胺(MDMA)增加了自我报告的积极社交感受,并降低了识别面部社交威胁的能力,但它对社交接受和拒绝的体验的影响尚未确定。我们研究了急性 MDMA 剂量如何影响模拟社交接受和拒绝的主观和自主反应。我们预测 MDMA 会降低对拒绝的主观反应。在此基础上,我们还探讨了 MDMA 对呼吸窦性心律失常(RSA)的影响,RSA 是一种自主神经心脏控制的测量方法,通常被认为是社交参与和情绪调节的指标。在三个阶段中,有 MDMA 既往使用经验的健康成年志愿者(N=36)在平衡双盲条件下接受安慰剂、0.75 或 1.5 mg/kg 的 MDMA 胶囊。在预期的药物峰值作用期间,参与者在称为“Cyberball”的虚拟社交模拟任务中玩了两轮,其中一轮接受,另一轮拒绝。在任务期间,我们还获得了心电图(ECG),从中计算出 RSA。每轮之后,参与者回答关于他们的情绪和自尊的问卷。正如预测的那样,MDMA 降低了模拟社交拒绝对自我报告的情绪和自尊的影响,并降低了感知到的拒绝强度,以参与者报告收到的投掷球的百分比来衡量。与它的拟交感神经特性一致,MDMA 降低了与安慰剂相比的 RSA。我们发现 MDMA 降低了对模拟社交情境中拒绝的感知,这一结果扩展了先前的研究结果,表明 MDMA 降低了对脸部社交威胁的感知。这些发现共同表明了一种认知机制,通过该机制,MDMA 可能产生亲社会行为和感觉,以及药物如何作为心理治疗的辅助手段发挥作用。这些现象值得在非模拟社交环境中进一步研究。